ID

26737

Descrição

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Third party follow-up - Repeating form (Scheduled/Dynamic visit)

Palavras-chave

Versões (3)
  1. 12/10/2017 12/10/2017 -
  2. 23/10/2017 23/10/2017 -
  3. 02/01/2018 02/01/2018 -
Titular dos direitos

GlaxoSmithKline

Transferido a

23 de outubro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

Inglês

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulários  
Date of last contact attempt
Descrição

Date of last contact attempt

1. Date of most recent attempt to contact third party
Descrição

Date of last contact attempt

Tipo de dados

date

Contact details
Descrição

Contact details

2. Was contact successful? (i.e. actually spoke to someone)
Descrição

contact successful

Tipo de dados

boolean

If contact successful: Type of third party contact
Descrição

Type of third party contact

Tipo de dados

text

Other type of third party contact
Descrição

Other type of third party contact

Tipo de dados

text

Are there any new study endpoints to report?
Descrição

If Yes, complete SAE-EP and appropriate Endpoint forms.

Tipo de dados

text

Date endpoint information assessed by third party
Descrição

Date endpoint information assessed by third party

Tipo de dados

date

Voltar ao início da página

Similar models

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Date of last contact attempt
Date of last contact attempt
Item
1. Date of most recent attempt to contact third party
date
Item Group
Contact details
contact successful
Item
2. Was contact successful? (i.e. actually spoke to someone)
boolean
Item
If contact successful: Type of third party contact
text
Type of third party contact
Code List
If contact successful: Type of third party contact
CL Item
Investigative site staff (4)
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Friend or neighbor (5)
CL Item
Other (OT)
Other type of third party contact
Item
Other type of third party contact
text
Item
Are there any new study endpoints to report?
text
new study endpoints
Code List
Are there any new study endpoints to report?
CL Item
Unknown (Third party not able to find out if subject did or did not have new study endpoint, or the only information available is vital status "death" without details) (U)
CL Item
No (Third party able to confirm no new study endpoints) (N)
CL Item
Yes (Third party able to confirm the presence of new study endpoints. Do not select this option if the only information available is vital status "death" without details) (Y)
Date endpoint information assessed by third party
Item
Date endpoint information assessed by third party
date
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial